The Latest Headlines at ETF Daily News
Analysts Issue Forecasts for Decisive Dividend Co.’s Q1 2024 Earnings (CVE:DE)
Decisive Dividend Co. (CVE:DE – Free Report) – Equities research analysts at Echelon Wealth Partners issued their Q1 2024 earnings per share (EPS) estimates for Decisive Dividend in a research note issued to investors... More of this article »
Brokers Offer Predictions for Boyd Group Services Inc.’s Q1 2024 Earnings (TSE:BYD)
Boyd Group Services Inc. (TSE:BYD – Free Report) – Analysts at Raymond James issued their Q1 2024 earnings per share estimates for Boyd Group Services in a research report issued on Thursday, March 21st. Raymond James... More of this article »
Zacks Research Analysts Reduce Earnings Estimates for Viper Energy, Inc. (NASDAQ:VNOM)
Viper Energy, Inc. (NASDAQ:VNOM – Free Report) – Equities research analysts at Zacks Research dropped their Q1 2024 EPS estimates for Viper Energy in a research report issued on Friday, March 22nd. Zacks Research analyst... More of this article »
Brookline Capital Management Research Analysts Lower Earnings Estimates for X4 Pharmaceuticals, Inc. (NASDAQ:XFOR)
X4 Pharmaceuticals, Inc. (NASDAQ:XFOR – Free Report) – Brookline Capital Management lowered their Q1 2024 earnings per share (EPS) estimates for X4 Pharmaceuticals in a research report issued on Thursday, March 21st.... More of this article »
Desjardins Boosts Enerplus (TSE:ERF) Price Target to C$19.25
Enerplus (TSE:ERF – Free Report) (NYSE:ERF) had its target price increased by Desjardins from C$17.50 to C$19.25 in a research note published on Friday, BayStreet.CA reports. Desjardins currently has a tender rating on the oil... More of this article »
CIBC Raises Imperial Oil (TSE:IMO) Price Target to C$90.00
Imperial Oil (TSE:IMO – Free Report) (NYSEMKT:IMO) had its price objective increased by CIBC from C$85.00 to C$90.00 in a research report sent to investors on Friday morning, BayStreet.CA reports. CIBC currently has a neutral... More of this article »
Financial Comparison: CannaPharmaRX (OTCMKTS:CPMD) and Savara (NASDAQ:SVRA)
CannaPharmaRX (OTCMKTS:CPMD – Get Free Report) and Savara (NASDAQ:SVRA – Get Free Report) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of... More of this article »
Royal Bank of Canada Boosts Knight Therapeutics (TSE:GUD) Price Target to C$7.00
Knight Therapeutics (TSE:GUD – Free Report) had its price target raised by Royal Bank of Canada from C$6.50 to C$7.00 in a research note released on Friday morning, BayStreet.CA reports. They currently have an outperform rating... More of this article »
Contrasting Sientra (NASDAQ:SIEN) & Demant A/S (OTCMKTS:WILLF)
Sientra (NASDAQ:SIEN – Get Free Report) and Demant A/S (OTCMKTS:WILLF – Get Free Report) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their... More of this article »
United Homes Group (UHG) and Its Competitors Head-To-Head Comparison
United Homes Group (NASDAQ:UHG – Get Free Report) is one of 23 publicly-traded companies in the “Operative builders” industry, but how does it compare to its competitors? We will compare United Homes Group to similar... More of this article »
Enbridge Inc. (NYSE:ENB) Given Average Recommendation of “Hold” by Brokerages
Enbridge Inc. (NYSE:ENB – Get Free Report) (TSE:ENB) has received a consensus rating of “Hold” from the eleven ratings firms that are covering the firm, MarketBeat reports. Two equities research analysts have rated... More of this article »
e.l.f. Beauty, Inc. (NYSE:ELF) Given Consensus Rating of “Moderate Buy” by Brokerages
e.l.f. Beauty, Inc. (NYSE:ELF – Get Free Report) has received an average recommendation of “Moderate Buy” from the twelve analysts that are covering the firm, MarketBeat.com reports. Four investment analysts have... More of this article »
United Airlines Holdings, Inc. (NASDAQ:UAL) Receives Average Rating of “Moderate Buy” from Analysts
United Airlines Holdings, Inc. (NASDAQ:UAL – Get Free Report) has earned a consensus rating of “Moderate Buy” from the thirteen research firms that are covering the firm, MarketBeat reports. Three investment analysts... More of this article »